Bcl-2	B-protein
protein	I-protein
inhibits	O
bufalin-induced	O
apoptosis	O
through	O
inhibition	O
of	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
activation	O
in	O
human	B-cell_line
leukemia	I-cell_line
U937	I-cell_line
cells	I-cell_line
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
demonstrated	O
that	O
bufalin	O
,	O
which	O
is	O
an	O
active	O
principle	O
of	O
Chinese	O
medicine	O
,	O
chan'su	O
,	O
caused	O
apoptosis	O
in	O
human	B-cell_line
leukemia	I-cell_line
U937	I-cell_line
cells	I-cell_line
by	O
anomalous	O
activation	O
of	O
mitogen-activated	B-protein
protein	I-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
via	O
the	O
signaling	O
pathway	O
of	O
Ras	B-protein
,	O
Raf-1	B-protein
,	O
and	O
MAPK	B-protein
kinase-1	I-protein
.	O

Here	O
,	O
we	O
report	O
the	O
effect	O
of	O
overexpression	O
of	O
bcl-2	B-protein
in	O
U937	B-cell_line
cells	I-cell_line
on	O
the	O
signaling	O
pathway	O
of	O
apoptosis	O
that	O
is	O
induced	O
by	O
bufalin	O
.	O

The	O
results	O
indicated	O
that	O
the	O
apoptosis	O
induced	O
by	O
bufalin	O
in	O
U937	B-cell_line
cells	I-cell_line
was	O
significantly	O
inhibited	O
by	O
overexpression	O
of	O
the	O
Bcl-2	B-protein
protein	I-protein
.	O

No	O
significant	O
difference	O
was	O
detected	O
in	O
the	O
activation	O
of	O
MAPK	B-protein
kinase-1	I-protein
that	O
is	O
induced	O
by	O
bufalin	O
in	O
wild-type	O
or	O
Bcl-2-overexpressed	B-cell_type
U937	I-cell_type
cells	I-cell_type
;	O
however	O
,	O
the	O
activation	O
of	O
MAPK	B-protein
by	O
bufalin	O
was	O
significantly	O
attenuated	O
in	O
the	O
cells	O
overexpressing	O
Bcl-2	B-protein
.	O

Bufalin	O
treatment	O
activated	B-protein
activator	I-protein
protein-1	I-protein
transcriptional	O
activity	O
;	O
however	O
,	O
this	O
activation	O
was	O
decreased	O
to	O
40	O
%	O
in	O
bcl-2	B-protein
-overexpressed	O
U937	B-cell_line
cells	I-cell_line
.	O

These	O
results	O
indicate	O
that	O
Bcl-2	B-protein
acts	O
downstream	O
of	O
MAPK	B-protein
kinase-1	I-protein
but	O
upstream	O
of	O
MAPK	B-protein
and	O
suggest	O
that	O
,	O
in	O
the	O
signaling	O
pathway	O
of	O
the	O
apoptotic	O
process	O
induced	O
by	O
bufalin	O
,	O
the	O
transcriptional	O
activity	O
of	O
activator	B-protein
protein-1	I-protein
may	O
be	O
down-regulated	O
through	O
the	O
inhibition	O
of	O
MAPK	B-protein
activity	O
by	O
Bcl-2	B-protein
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
57	NULL
,	NULL
3097-3100	NULL
,	NULL
August	NULL
1	NULL
,	NULL
1997	NULL
]	NULL
Advances	NULL
in	NULL
Brief	NULL
Bcl-2	NULL
Protein	NULL
Inhibits	NULL
Bufalin-induced	NULL
Apoptosis	NULL
through	NULL
Inhibition	NULL
of	NULL
Mitogenactivated	NULL
Protein	NULL
Kinase	NULL
Activation	NULL
in	NULL
Human	NULL
Leukemia	NULL
U937	NULL
Cells	NULL
!	NULL

Masahiko	NULL
Watabe	NULL
,	NULL
Nobuko	NULL
Kawazoe	NULL
,	NULL
Yutaka	NULL
Masuda	NULL
,	NULL
Shigeo	NULL
Nakajo	NULL
,	NULL
and	NULL
Kazuyasu	NULL
Nakaya*	NULL
Laboratory	NULL
of	NULL
Biological	NULL
Chemistry	NULL
,	NULL
School	NULL
of	NULL
Pharmaceutical	NULL
Sciences	NULL
,	NULL
Showa	NULL
University	NULL
,	NULL
1-5-8	NULL
Hatanodai	NULL
,	NULL
Shinagawa-ku	NULL
,	NULL
Tokyo	NULL
142	NULL
,	NULL
Japan	NULL
Abstract	NULL
In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
bufalin	NULL
,	NULL
which	NULL
is	NULL
an	NULL
active	NULL
principle	NULL
of	NULL
Chinese	NULL
medicine	NULL
,	NULL
chan'su	NULL
,	NULL
caused	NULL
apoptosis	NULL
in	NULL
human	NULL
leukemia	NULL
U937	NULL
cells	NULL
by	NULL
anomalous	NULL
activation	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
via	NULL
the	NULL
signaling	NULL
pathway	NULL
of	NULL
Ras	NULL
,	NULL
Raf-1	NULL
,	NULL
and	NULL
MAPK	NULL
kinase-1	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
the	NULL
effect	NULL
of	NULL
overexpression	NULL
of	NULL
bei-2	NULL
in	NULL
U937	NULL
cells	NULL
on	NULL
the	NULL
signaling	NULL
pathway	NULL
of	NULL
apoptosis	NULL
that	NULL
is	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

The	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
apoptosis	NULL
induced	NULL
by	NULL
bufalin	NULL
in	NULL
U937	NULL
cells	NULL
was	NULL
significantly	NULL
inhibited	NULL
by	NULL
overexpression	NULL
of	NULL
the	NULL
Bcl-2	NULL
protein	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
kinase-1	NULL
that	NULL
is	NULL
induced	NULL
by	NULL
bufalin	NULL
in	NULL
wild-type	NULL
or	NULL
Bcl-2-overexpressed	NULL
U937	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
by	NULL
bufalin	NULL
was	NULL
significantly	NULL
attenuated	NULL
in	NULL
the	NULL
cells	NULL
overexpressing	NULL
Bcl-2	NULL
.	NULL

Bufalin	NULL
treatment	NULL
activated	NULL
activator	NULL
protein-1	NULL
transcriptional	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
this	NULL
activation	NULL
was	NULL
decreased	NULL
to	NULL
40	NULL
%	NULL
in	NULL
bel-2-overexpressed	NULL
U937	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Bcl-2	NULL
acts	NULL
downstream	NULL
of	NULL
MAPK	NULL
kinase-1	NULL
but	NULL
upstream	NULL
of	NULL
MAPK	NULL
and	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
the	NULL
signaling	NULL
pathway	NULL
of	NULL
the	NULL
apoptotic	NULL
process	NULL
induced	NULL
by	NULL
bufalin	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
activator	NULL
protein-1	NULL
may	NULL
be	NULL
down-regulated	NULL
through	NULL
the	NULL
inhibition	NULL
of	NULL
MAPK	NULL
activity	NULL
by	NULL
Bcl-2	NULL
.	NULL

Introduction	NULL
Several	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
either	NULL
inducers	NULL
or	NULL
repressors	NULL
of	NULL
apoptosis	NULL
.	NULL

Among	NULL
these	NULL
is	NULL
bel-2	NULL
(	NULL
B-cell	NULL
lymphoma-2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
known	NULL
as	NULL
an	NULL
antiapoptotic	NULL
gene	NULL
.	NULL

It	NULL
was	NULL
first	NULL
discovered	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
t	NULL
(	NULL
14	NULL
;	NULL
18	NULL
)	NULL
chromosomal	NULL
translocations	NULL
found	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
non-Hodgkin	NULL
's	NULL
B-cell	NULL
lymphomas	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
biochemical	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
this	NULL
M	NULL
,	NULL
25,000-26,000	NULL
Bel-2	NULL
protein	NULL
remains	NULL
enigmatic	NULL
.	NULL

The	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
Bcl-2	NULL
shares	NULL
no	NULL
significant	NULL
homology	NULL
with	NULL
other	NULL
proteins	NULL
having	NULL
known	NULL
functions	NULL
.	NULL

Hockenbery	NULL
et	NULL
al	NULL
.	NULL

(	NULL
3	NULL
)	NULL
proposed	NULL
that	NULL
Bcl-2	NULL
functions	NULL
in	NULL
an	NULL
antioxidant	NULL
pathway	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
Steinman	NULL
proposed	NULL
that	NULL
Bcl-2	NULL
acts	NULL
as	NULL
a	NULL
pro-oxidant	NULL
,	NULL
generating	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
in	NULL
Escherichia	NULL
coli	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Oltvai	NULL
et	NULL
al	NULL
.	NULL

(	NULL
5	NULL
)	NULL
suggested	NULL
that	NULL
some	NULL
functions	NULL
of	NULL
Bcl-2	NULL
are	NULL
mediated	NULL
through	NULL
the	NULL
interaction	NULL
with	NULL
Bax	NULL
,	NULL
a	NULL
Bcl-2	NULL
homologue	NULL
.	NULL

Recently	NULL
,	NULL
Bcl-2	NULL
protein	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
physically	NULL
associated	NULL
with	NULL
p72	NULL
Raf-1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
serine/threonine-specific	NULL
protein	NULL
kinase	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
with	NULL
p23-R-Ras	NULL
(	NULL
7	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
GTPase	NULL
member	NULL
of	NULL
the	NULL
Ras	NULL
family	NULL
(	NULL
8	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
this	NULL
antiapoptotic	NULL
protein	NULL
may	NULL
participate	NULL
in	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
via	NULL
Ras/Raf-1	NULL
.	NULL

In	NULL
cotransfection	NULL
studies	NULL
using	NULL
a	NULL
diploid	NULL
hematopoietic	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
elevations	NULL
in	NULL
the	NULL
Bcl-2	NULL
protein	NULL
level	NULL
and	NULL
Raf-1	NULL
kinase	NULL
activity	NULL
was	NULL
shown	NULL
to	NULL
provide	NULL
synergistic	NULL
protection	NULL
to	NULL
the	NULL
cell	NULL
from	NULL
death	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
withdrawal	NULL
(	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
function	NULL
of	NULL
Raf-1	NULL
and	NULL
the	NULL
significance	NULL
of	NULL
its	NULL
interaction	NULL
with	NULL
Bel-2	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
death	NULL
remains	NULL
unclear	NULL
.	NULL

Received	NULL
3/26/97	NULL
;	NULL
accepted	NULL
6/12/97	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Grants-in-Aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Phone	NULL
:	NULL
81-3-3784-8217	NULL
;	NULL
Fax	NULL
:	NULL
81-3-3784-8219	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
bufalin	NULL
,	NULL
which	NULL
is	NULL
one	NULL
of	NULL
the	NULL
components	NULL
of	NULL
bufadienolides	NULL
in	NULL
the	NULL
traditional	NULL
Chinese	NULL
medicine	NULL
,	NULL
chan'su	NULL
,	NULL
and	NULL
which	NULL
is	NULL
prepared	NULL
from	NULL
toad	NULL
venom	NULL
,	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
various	NULL
human	NULL
tumor	NULL
cell	NULL
lines	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
bufalin	NULL
causes	NULL
an	NULL
anomalous	NULL
activation	NULL
of	NULL
MAPK	NULL
via	NULL
Ras	NULL
in	NULL
promonocytic	NULL
leukemia	NULL
U937	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
persistent	NULL
activation	NULL
of	NULL
MAPK	NULL
in	NULL
U937	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
bufalin	NULL
was	NULL
caused	NULL
by	NULL
the	NULL
cooperative	NULL
interaction	NULL
of	NULL
two	NULL
different	NULL
signaling	NULL
pathways	NULL
.	NULL

Namely	NULL
,	NULL
Raf-1	NULL
was	NULL
activated	NULL
both	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
Ras	NULL
and	NULL
by	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
cAMP	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
Bcl-2	NULL
protein	NULL
on	NULL
the	NULL
MAPK	NULL
cascade	NULL
and	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
the	NULL
apoptotic	NULL
process	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
.	NULL

Human	NULL
promonocytic	NULL
leukemia	NULL
U937	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resources	NULL
Bank	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
at	NULL
37°C	NULL
under	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

Chemicals	NULL
and	NULL
Radioisotopes	NULL
.	NULL

Bufalin	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St	NULL
,	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
luciferase	NULL
assay	NULL
system	NULL
was	NULL
from	NULL
Promega	NULL
,	NULL
and	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Amersham	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Geneticin	NULL
(	NULL
G418	NULL
sulfate	NULL
)	NULL
and	NULL
an	NULL
antibody	NULL
against	NULL
Bcl-2	NULL
were	NULL
from	NULL
Wako	NULL
Pure	NULL
Chemical	NULL
Industries	NULL
,	NULL
Ltd.	NULL
(	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

The	NULL
peptides	NULL
,	NULL
FLTEYVATRWYRAPEIMLN	NULL
and	NULL
KRELVEPLTPAGEAPN-QALLR	NULL
,	NULL
were	NULL
chemically	NULL
synthesized	NULL
with	NULL
a	NULL
model	NULL
431A	NULL
peptide	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Cleavage	NULL
from	NULL
the	NULL
4-hydroxymethylphenoxy-methylpolystyrene-resin	NULL
was	NULL
performed	NULL
with	NULL
95	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
TFA	NULL
.	NULL

The	NULL
peptides	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
C8	NULL
reverse-phase	NULL
high-performance	NULL
liquid	NULL
chromatography	NULL
column	NULL
(	NULL
Prep-10	NULL
Aquapore	NULL
,	NULL
10	NULL
x	NULL
250	NULL
mm	NULL
)	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
TFA	NULL
and	NULL
then	NULL
eluted	NULL
with	NULL
a	NULL
linear	NULL
gradient	NULL
of	NULL
0O-70	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
acetnitrile	NULL
containing	NULL
0.1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
TFA	NULL
,	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
3	NULL
ml/min	NULL
for	NULL
60	NULL
min	NULL
.	NULL

Construction	NULL
of	NULL
Expression	NULL
Vector	NULL
.	NULL

The	NULL
0.9-kb	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
a	NULL
human	NULL
be/-2	NULL
cDNA	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
HinclI	NULL
site	NULL
of	NULL
a	NULL
pUCI19	NULL
cloning	NULL
vector	NULL
.	NULL

The	NULL
insert	NULL
was	NULL
cut	NULL
with	NULL
Xbal	NULL
and	NULL
HindIII	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
Xbal	NULL
and	NULL
HindIII	NULL
restriction	NULL
sites	NULL
of	NULL
a	NULL
pRc-RSV	NULL
expression	NULL
vector	NULL
.	NULL

Transfection	NULL
of	NULL
U937	NULL
Cells	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
electropo-ration	NULL
(	NULL
Bio-Rad	NULL
Gene	NULL
Pulsor	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
)	NULL
.	NULL

A	NULL
pulse	NULL
was	NULL
delivered	NULL
to	NULL
a	NULL
0.4-ml	NULL
U937	NULL
cell	NULL
suspension	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
.	NULL

The	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
)	NULL
were	NULL
plated	NULL
onto	NULL
96-well	NULL
microplates	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
geneticin	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
400	NULL
ug/ml	NULL
,	NULL
and	NULL
the	NULL
subclones	NULL
were	NULL
isolated	NULL
2-3	NULL
weeks	NULL
later	NULL
.	NULL

RNA	NULL
Isolation	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Chomczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
15	NULL
pug	NULL
of	NULL
RNA	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
denatured	NULL
agarose	NULL
gel	NULL
containing	NULL
formaldehyde	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Hybond-N	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Bufalin	NULL
Treatment	NULL
.	NULL

Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
U937	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
deprived	NULL
of	NULL
serum	NULL
for	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
bufalin	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10~°	NULL
m	NULL
bufalin	NULL
in	NULL
the	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
for	NULL
the	NULL
times	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-1	NULL
;	NULL
TFA	NULL
,	NULL
trifluoroacetic	NULL
acid	NULL
;	NULL
TBS	NULL
,	NULL
Tris-buffered	NULL
saline	NULL
;	NULL
DAPI	NULL
,	NULL
4',6-diamidine-2-phenylindole	NULL
dihydrochloride	NULL
;	NULL
MAPKK	NULL
,	NULL
MAPK	NULL
kinase	NULL
.	NULL

3097	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

THE	NULL
MECHANISM	NULL
OF	NULL
APOPTOSIS	NULL
INHIBITION	NULL
BY	NULL
Bcl-2	NULL
PROTEIN	NULL
indicated	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
counting	NULL
the	NULL
cells	NULL
that	NULL
excluded	NULL
trypan	NULL
blue	NULL
dye	NULL
.	NULL

Preparation	NULL
of	NULL
Cell	NULL
Lysate	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
washed	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
0.4	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
consisting	NULL
of	NULL
10	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
EGTA	NULL
,	NULL
0.15	NULL
m	NULL
NaCl	NULL
,	NULL
5	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
5	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
5	NULL
pg/ml	NULL
pepstatin	NULL
A	NULL
,	NULL
5	NULL
.	NULL

ug/ml	NULL
antipain	NULL
,	NULL
0.5	NULL
mm	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
50	NULL
mm	NULL
NaF	NULL
,	NULL
2	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mm	NULL
Na	NULL
PP	NULL
,	NULL
,	NULL
and	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Triton	NULL
X-100	NULL
.	NULL

The	NULL
cell	NULL
lysate	NULL
was	NULL
centrifuged	NULL
at	NULL
15,000	NULL
%	NULL
g	NULL
for	NULL
20	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
thus	NULL
obtained	NULL
was	NULL
used	NULL
for	NULL
immunoblotting	NULL
and	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
protein	NULL
kinase	NULL
activities	NULL
.	NULL

Inimunoblotting	NULL
.	NULL

Cell	NULL
lysates	NULL
containing	NULL
20	NULL
ug	NULL
of	NULL
protein	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
diflu-oride	NULL
membrane	NULL
using	NULL
a	NULL
wet	NULL
blotting	NULL
apparatus	NULL
at	NULL
0.5	NULL
V/em*	NULL
constant	NULL
voltage	NULL
for	NULL
3.5	NULL
h	NULL
in	NULL
an	NULL
ice-cold	NULL
bath	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
first	NULL
washed	NULL
with	NULL
20	NULL
mm	NULL
Tris-HCl	NULL
buffer	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
containing	NULL
0.15	NULL
m	NULL
NaCl	NULL
(	NULL
TBS	NULL
)	NULL
and	NULL
then	NULL
blocked	NULL
with	NULL
3	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
in	NULL
TBS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
blocked	NULL
membrane	NULL
was	NULL
subsequently	NULL
probed	NULL
with	NULL
the	NULL
anti-Bcl-2	NULL
antibody	NULL
,	NULL
diluted	NULL
1:1000	NULL
in	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Tween	NULL
20	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
antimouse	NULL
IgG	NULL
(	NULL
H	NULL
&	NULL
L	NULL
;	NULL
American	NULL
Qualex	NULL
)	NULL
,	NULL
diluted	NULL
1:2000	NULL
in	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
BSA	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
washed	NULL
with	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Tween	NULL
20	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
bands	NULL
visualized	NULL
by	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
.	NULL

Analysis	NULL
of	NULL
DNA	NULL
Fragmentation	NULL
by	NULL
Agarose	NULL
Gel	NULL
Electrophoresis	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
washed	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
a	NULL
solution	NULL
consisting	NULL
of	NULL
10	NULL
mm	NULL
Tris-HC	NULL
]	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
SDS	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
RNase	NULL
A	NULL
and	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
50°C	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
min	NULL
at	NULL
50°C	NULL
with	NULL
1	NULL
mg/ml	NULL
proteinase	NULL
K	NULL
and	NULL
then	NULL
electrophoresed	NULL
on	NULL
a	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
agarose	NULL
gel	NULL
in	NULL
40	NULL
mm	NULL
Tris-acetate	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
containing	NULL
1	NULL
mM	NULL
EDTA	NULL
for	NULL
60	NULL
min	NULL
at	NULL
50	NULL
V.	NULL
After	NULL
electrophoresis	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
visualized	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

Quantification	NULL
of	NULL
DNA	NULL
Fragmentation	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
a	NULL
solution	NULL
consisting	NULL
of	NULL
5	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Triton	NULL
X-100	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
centrifuged	NULL
at	NULL
27,000	NULL
x	NULL
g	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
the	NULL
fragmented	NULL
DNA	NULL
was	NULL
recovered	NULL
from	NULL
the	NULL
supernatant	NULL
.	NULL

The	NULL
pellets	NULL
remaining	NULL
in	NULL
the	NULL
centrifugation	NULL
tube	NULL
was	NULL
sonicated	NULL
for	NULL
1	NULL
min	NULL
at	NULL
45	NULL
W.	NULL
The	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
fluorometric	NULL
method	NULL
using	NULL
DAPI	NULL
.	NULL

The	NULL
fluorescence	NULL
intensity	NULL
was	NULL
measured	NULL
at	NULL
454	NULL
nm	NULL
,	NULL
with	NULL
the	NULL
excitation	NULL
at	NULL
362	NULL
nm	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
DNA	NULL
fragmentation	NULL
was	NULL
defined	NULL
as	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
fragmented	NULL
DNA	NULL
to	NULL
the	NULL
total	NULL
DNA	NULL
.	NULL

Luciferase	NULL
Assay	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
(	NULL
-517	NULL
to	NULL
+63	NULL
)	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
containing	NULL
the	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
response	NULL
element	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
.	NULL

Human	NULL
genomic	NULL
DNA	NULL
was	NULL
isolated	NULL
from	NULL
U937	NULL
cells	NULL
and	NULL
dissolved	NULL
in	NULL
PCR	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
KCI	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
A	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
50	NULL
pmol	NULL
of	NULL
the	NULL
forward	NULL
primer	NULL
(	NULL
ACTCGAGGGTACCAG-GCAGCTTAACAA	NULL
)	NULL
,	NULL
and	NULL
50	NULL
pmol	NULL
of	NULL
reverse	NULL
primer	NULL
(	NULL
AAGATCTCCHIT-GTCTTCTTTCTCAGTG	NULL
)	NULL
.	NULL

The	NULL
PCRs	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.5	NULL
units	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
Cetus	NULL
)	NULL
for	NULL
40	NULL
cycles	NULL
using	NULL
a	NULL
step	NULL
program	NULL
(	NULL
94°C	NULL
,	NULL
1	NULL
min	NULL
;	NULL
55°C	NULL
,	NULL
1	NULL
min	NULL
;	NULL
and	NULL
72°C	NULL
,	NULL
2	NULL
min	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
7-min	NULL
final	NULL
extension	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
0.5-kb	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Xhol	NULL
and	NULL
Bgill	NULL
sites	NULL
of	NULL
a	NULL
Pica	NULL
gene	NULL
basic	NULL
vector	NULL
(	NULL
Toyo	NULL
Inki	NULL
Co.	NULL
)	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
this	NULL
vector	NULL
using	NULL
lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10~°	NULL
m	NULL
bufalin	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
the	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
centrifuged	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
collected	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
a	NULL
luciferase	NULL
assay	NULL
system	NULL
.	NULL

In	NULL
Vitro	NULL
Kinase	NULL
Assay	NULL
Using	NULL
a	NULL
Synthetic	NULL
Peptide	NULL
.	NULL

MAPKK	NULL
and	NULL
MAPK	NULL
activities	NULL
were	NULL
measured	NULL
in	NULL
cell	NULL
lysates	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
prepared	NULL
from	NULL
the	NULL
expression	NULL
vector-transfected	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
.	NULL

The	NULL
MAPKK	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
of	NULL
assay	NULL
mixture	NULL
consisting	NULL
of	NULL
50	NULL
um	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
0.1	NULL
mCi	NULL
)	NULL
,	NULL
40	NULL
ug	NULL
of	NULL
cell	NULL
lysate	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
synthetic	NULL
peptide	NULL
(	NULL
FLTEYVATRWYRAPEIMLN	NULL
)	NULL
,	NULL
12.5	NULL
mm	NULL
MOPS	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
12.5	NULL
mm	NULL
b-glycerophosphate	NULL
,	NULL
7.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
EGTA	NULL
,	NULL
0.05	NULL
mm	NULL
NaF	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.5	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
30°C	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
1	NULL
N	NULL
HCI	NULL
.	NULL

After	NULL
boiling	NULL
for	NULL
10	NULL
min	NULL
,	NULL
1	NULL
ml	NULL
of	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
TFA	NULL
was	NULL
added	NULL
to	NULL
the	NULL
sample	NULL
,	NULL
and	NULL
it	NULL
was	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
Sep-pak	NULL
C18	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
TFA	NULL
,	NULL
and	NULL
the	NULL
substrate	NULL
peptide	NULL
was	NULL
eluted	NULL
with	NULL
100	NULL
%	NULL
acetonitrile	NULL
.	NULL

The	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
the	NULL
peptide	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

The	NULL
MAPK	NULL
assay	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
30	NULL
pl	NULL
of	NULL
assay	NULL
mixture	NULL
containing	NULL
50	NULL
um	NULL
[	NULL
y-°P	NULL
]	NULL
ATP	NULL
(	NULL
0.1	NULL
mCi	NULL
)	NULL
,	NULL
40	NULL
ug	NULL
of	NULL
cell	NULL
lysate	NULL
,	NULL
2	NULL
mm	NULL
synthetic	NULL
peptide	NULL
(	NULL
KRELVEPLTPAGEAPNQALLR	NULL
)	NULL
,	NULL
25	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
1.5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
and	NULL
0.1	NULL
mm	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
30°C	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
300	NULL
mM	NULL
orthophosphoric	NULL
acid	NULL
,	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
spotted	NULL
onto	NULL
a	NULL
1.5-cm*	NULL
Whatman	NULL
P81	NULL
disc	NULL
of	NULL
phosphocellulose	NULL
paper	NULL
.	NULL

The	NULL
papers	NULL
were	NULL
washed	NULL
in	NULL
1	NULL
%	NULL
phosphoric	NULL
acid	NULL
more	NULL
than	NULL
seven	NULL
times	NULL
by	NULL
shaking	NULL
for	NULL
at	NULL
least	NULL
5	NULL
min	NULL
.	NULL

The	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
substrate	NULL
peptide	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

Results	NULL
Expression	NULL
of	NULL
be/-2	NULL
mRNA	NULL
in	NULL
Transfected	NULL
U937	NULL
Cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Bcl-2	NULL
protein	NULL
in	NULL
the	NULL
bufalin-induced	NULL
apoptotic	NULL
process	NULL
,	NULL
the	NULL
be/-2	NULL
gene	NULL
was	NULL
introduced	NULL
into	NULL
human	NULL
leukemia	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
be/-2	NULL
mRNA	NULL
in	NULL
eight	NULL
clones	NULL
of	NULL
G418-resistant	NULL
cells	NULL
was	NULL
evaluated	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
be/-2	NULL
mRNA	NULL
could	NULL
scarcely	NULL
be	NULL
detected	NULL
in	NULL
both	NULL
parental	NULL
cells	NULL
(	NULL
U937y-	NULL
)	NULL
and	NULL
cells	NULL
transfected	NULL
with	NULL
#	NULL
y	NULL
#	NULL
>	NULL
y	NULL
>	NULL
y	NULL
§	NULL
Sy	NULL
``	NULL
§	NULL
Wp	NULL
I	NULL
$	NULL
&	NULL
i	NULL
yi	NULL
<	NULL
i	NULL
sg	NULL
Top	NULL
>	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
be/-2	NULL
mRNA	NULL
and	NULL
Bcl-2	NULL
protein	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
U937	NULL
cells	NULL
,	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
RNA	NULL
were	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
20	NULL
pg	NULL
of	NULL
protein	NULL
)	NULL
prepared	NULL
from	NULL
U937	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
28S	NULL
>	NULL
66	NULL
>	NULL
immunoblotting	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
human	NULL
Bci-2	NULL
(	NULL
B	NULL
)	NULL
.	NULL

U937y4	NULL
.	NULL

wild-type	NULL
U937	NULL
cells	NULL
;	NULL
U937	NULL
,	NULL
,	NULL
45y	NULL
©	NULL
U937	NULL
cells	NULL
transfected	NULL
with	NULL
pRc-RSV	NULL
expression	NULL
vector	NULL
alone	NULL
;	NULL
U937	NULL
,	NULL
.	NULL

»	NULL
.	NULL

and	NULL
U937	NULL
cells	NULL
transfected	NULL
with	NULL
pRc-RSV	NULL
vector	NULL
carrying	NULL
the	NULL
188	NULL
>	NULL
eDNA	NULL
of	NULL
human	NULL
bel-2	NULL
.	NULL

-	NULL
<	NULL
bel-2	NULL
29	NULL
>	NULL
Bel-2	NULL
Cl-	NULL
ste-	NULL
cea	NULL
ﬁ-	NULL
<	NULL
«	NULL
€	NULL
20.1	NULL
»	NULL
Bottom	NULL
»	NULL
3098	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

THE	NULL
MECHANISM	NULL
OF	NULL
APOPTOSIS	NULL
INHIBITION	NULL
BY	NULL
Bcl-2	NULL
PROTEIN	NULL
B	NULL
100	NULL
%	NULL
0	NULL
6	NULL
0	NULL
-	NULL
r	NULL
p	NULL
>	NULL
<	NULL
J	NULL
a	NULL
5	NULL
75	NULL
int	NULL
a	NULL
:	NULL
r	NULL
§	NULL
so-	NULL
Sale	NULL
&	NULL
€	NULL
e	NULL
I	NULL
--	NULL
U937v	NULL
O	NULL
25	NULL
-	NULL
]	NULL
-A-	NULL
U937bcH2L	NULL
-M-0	NULL
U	NULL
t	NULL
I	NULL
U	NULL
U	NULL
0	NULL
6	NULL
1200	NULL
180	NULL
24	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
C	NULL
60	NULL
-	NULL
(	NULL
U97y	NULL
UB	NULL
Q	NULL
no	NULL
treatment	NULL
6	NULL
0	NULL
6	NULL
s	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
tn	NULL
l	NULL
umd	NULL
3	NULL
$	NULL
&	NULL
DNA	NULL
fragmentation	NULL
(	NULL
%	NULL
)	NULL
pna	NULL
&	NULL
1	NULL
&	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
overexpression	NULL
of	NULL
Bcl-2	NULL
proteins	NULL
on	NULL
cell	NULL
viability	NULL
and	NULL
DNA	NULL
fragmentation	NULL
.	NULL

Transfected	NULL
U937	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
deprived	NULL
of	NULL
serum	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
(	NULL
4	NULL
)	NULL
.	NULL

DNA	NULL
fragmentation	NULL
from	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
bufalin	NULL
for	NULL
6	NULL
h	NULL
was	NULL
analyzed	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
after	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
(	NULL
B	NULL
)	NULL
or	NULL
was	NULL
quantified	NULL
using	NULL
DAPI	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Data	NULL
points	NULL
(	NULL
A	NULL
)	NULL
and	NULL
columns	NULL
(	NULL
C	NULL
)	NULL
,	NULL
means	NULL
of	NULL
the	NULL
results	NULL
from	NULL
triplicate	NULL
assay	NULL
;	NULL
bars	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
,	NULL
SD	NULL
.	NULL

pRc-RSV	NULL
vector	NULL
alone	NULL
(	NULL
U937	NULL
,	NULL
)	NULL
,	NULL
a	NULL
significant	NULL
expression	NULL
of	NULL
be/-2	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
two	NULL
clones	NULL
transfected	NULL
with	NULL
a	NULL
pRc-RSV	NULL
vector	NULL
carrying	NULL
the	NULL
cDNA	NULL
of	NULL
human	NULL
bei-2	NULL
.	NULL

Relatively	NULL
low	NULL
and	NULL
high	NULL
bei-2-expressing	NULL
cells	NULL
were	NULL
designated	NULL
U937	NULL
,	NULL
_	NULL
,	NULL
,	NULL
,	NULL
and	NULL
U937	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
respectively	NULL
.	NULL

Cell	NULL
lysates	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
analyzed	NULL
with	NULL
an	NULL
antibody	NULL
against	NULL
Bcl-2	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

High	NULL
and	NULL
low	NULL
levels	NULL
of	NULL
Bel-2	NULL
protein	NULL
expression	NULL
were	NULL
detected	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
and	NULL
U937m1q	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
two	NULL
cell	NULL
lines	NULL
were	NULL
used	NULL
for	NULL
additional	NULL
experiments	NULL
.	NULL

Inhibition	NULL
of	NULL
Bufalin-induced	NULL
Apoptosis	NULL
by	NULL
Bel-2	NULL
.	NULL

To	NULL
avoid	NULL
the	NULL
effects	NULL
of	NULL
growth	NULL
factors	NULL
in	NULL
the	NULL
serum	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
medium	NULL
without	NULL
FCS	NULL
for	NULL
24	NULL
h	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
in	NULL
this	NULL
medium	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
measured	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
.	NULL

Cell	NULL
viability	NULL
of	NULL
the	NULL
U937	NULL
,	NULL
clone	NULL
was	NULL
decreased	NULL
by	NULL
the	NULL
bufalin	NULL
treatment	NULL
after	NULL
24	NULL
h	NULL
to	NULL
40	NULL
%	NULL
,	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
viability	NULL
obtained	NULL
for	NULL
U937wyf	NULL
,	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

As	NULL
compared	NULL
to	NULL
U937y	NULL
and	NULL
U937y4	NULL
cells	NULL
,	NULL
U937s.1.3	NULL
.	NULL

and	NULL
U937	NULL
,	NULL
,	NULL
;	NULL
,	NULL
;	NULL
,	NULL
clones	NULL
were	NULL
resistant	NULL
to	NULL
bufalin	NULL
treatment	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
the	NULL
suppression	NULL
of	NULL
cell	NULL
death	NULL
was	NULL
due	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
,	NULL
we	NULL
analyzed	NULL
DNA	NULL
fragmentation	NULL
induced	NULL
by	NULL
bufalin	NULL
in	NULL
these	NULL
clones	NULL
.	NULL

Following	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
of	NULL
U937	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
for	NULL
6	NULL
h	NULL
,	NULL
a	NULL
typical	NULL
ladder	NULL
200	NULL
C	NULL
€	NULL
3	NULL
175	NULL
3	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
overexpression	NULL
of	NULL
Bcl-2	NULL
protein	NULL
on	NULL
the	NULL
&	NULL
activation	NULL
of	NULL
MAPK	NULL
and	NULL
MAPKK-1	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

Trans-	NULL
7	NULL
,	NULL
150	NULL
fected	NULL
U937	NULL
cells	NULL
(	NULL
§	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
b	NULL
bufalin	NULL
for	NULL
6	NULL
h	NULL
for	NULL
MAPK	NULL
and	NULL
3	NULL
h	NULL
for	NULL
MAPKK-1	NULL
.	NULL

Activities	NULL
of	NULL
'S	NULL
MAPK	NULL
(	NULL
A	NULL
)	NULL
and	NULL
MAPKK	NULL
(	NULL
B	NULL
)	NULL
in	NULL
cell	NULL
lysates	NULL
(	NULL
40	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
®	NULL
125	NULL
were	NULL
determined	NULL
using	NULL
synthetic	NULL
peptides	NULL
as	NULL
described	NULL
under	NULL
&	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Columns	NULL
,	NULL
means	NULL
of	NULL
three	NULL
experiments	NULL
E	NULL
performed	NULL
in	NULL
triplicate	NULL
;	NULL
bars	NULL
,	NULL
SD	NULL
.	NULL

``	NULL
A	NULL
100	NULL
C.	NULL
<	NULL
ws	NULL
ps	NULL
pattern	NULL
of	NULL
internucleosomal	NULL
fragmentation	NULL
was	NULL
observed	NULL
,	NULL
which	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
an	NULL
early	NULL
event	NULL
of	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
DNA	NULL
fragmentation	NULL
in	NULL
4	NULL
and	NULL
U937	NULL
,	NULL
.	NULL
)	NULL

34	NULL
was	NULL
significantly	NULL
inhibited	NULL
.	NULL

Fragmented	NULL
DNA	NULL
was	NULL
quantified	NULL
by	NULL
the	NULL
fluorometric	NULL
method	NULL
using	NULL
DAPI	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
.	NULL

DNA	NULL
fragmentation	NULL
induced	NULL
in	NULL
U937	NULL
,	NULL
cells	NULL
was	NULL
49	NULL
%	NULL
,	NULL
which	NULL
is	NULL
almost	NULL
identical	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
U937-4	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
revealed	NULL
that	NULL
DNA	NULL
fragmentation	NULL
in	NULL
U937	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
and	NULL
_	NULL
,	NULL
,	NULL
induced	NULL
by	NULL
bufalin	NULL
decreased	NULL
to	NULL
70	NULL
and	NULL
36	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
U937y	NULL
.	NULL

This	NULL
result	NULL
was	NULL
consistent	NULL
with	NULL
that	NULL
of	NULL
the	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
apoptosis	NULL
induced	NULL
by	NULL
bufalin	NULL
in	NULL
U937	NULL
cells	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
Bcl-2	NULL
protein	NULL
.	NULL

Effect	NULL
of	NULL
Bel-2	NULL
Overexpression	NULL
on	NULL
Activation	NULL
of	NULL
MAPK	NULL
Cas-cade	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
bufalin	NULL
induces	NULL
activation	NULL
of	NULL
the	NULL
MAPK	NULL
signaling	NULL
pathway	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
MAPK	NULL
in	NULL
U937	NULL
,	NULL
cells	NULL
was	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
activation	NULL
of	NULL
MAPK	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
cells	NULL
caused	NULL
by	NULL
bufalin	NULL
was	NULL
quite	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
U937	NULL
,	NULL
,	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
was	NULL
significantly	NULL
suppressed	NULL
in	NULL
the	NULL
Bcl-2-overexpressing	NULL
cells	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
our	NULL
previous	NULL
report	NULL
(	NULL
10	NULL
)	NULL
,	NULL
MAPKK-1	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
cells	NULL
was	NULL
also	NULL
markedly	NULL
O	NULL
300	NULL
-	NULL
[	NULL
250	NULL
200	NULL
150	NULL
100	NULL
MAP	NULL
kinase	NULL
kinase	NULL
activity	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
C	NULL
no	NULL
treatment	NULL
{	NULL
J	NULL
bufalin	NULL
treatment	NULL
3099	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

THE	NULL
MECHANISM	NULL
OF	NULL
APOPTOSIS	NULL
INHIBITION	NULL
BY	NULL
Bcl-2	NULL
PROTEIN	NULL
[	NULL
]	NULL
no	NULL
treatment	NULL
©	NULL
)	NULL
bufatin	NULL
treatment	NULL
Relative	NULL
luciferase	NULL
activity	NULL
te	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
overexpression	NULL
of	NULL
Bel-2	NULL
protein	NULL
on	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

Transfected	NULL
U937	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
for	NULL
6	NULL
h.	NULL
Transcriptional	NULL
activity	NULL
of	NULL
AP-1	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Columns	NULL
,	NULL
means	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
triplicate	NULL
;	NULL
bars	NULL
,	NULL
SD	NULL
.	NULL

activated	NULL
by	NULL
bufalin	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
no	NULL
significant	NULL
inhibition	NULL
of	NULL
the	NULL
MAPKK-1	NULL
activation	NULL
induced	NULL
by	NULL
bufalin	NULL
was	NULL
observed	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
or	NULL
U937	NULL
,	NULL
,	NULL
.	NULL

,	NULL
,	NULL
,	NULL
,	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
Bcl-2	NULL
on	NULL
the	NULL
MAPK	NULL
activation	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Bcl-2	NULL
protein	NULL
acts	NULL
downstream	NULL
of	NULL
MAPKK-i	NULL
and	NULL
inhibits	NULL
the	NULL
activity	NULL
of	NULL
MAPK	NULL
.	NULL

Effect	NULL
of	NULL
Bcl-2	NULL
Overexpression	NULL
on	NULL
AP-1	NULL
Transcriptional	NULL
Activity	NULL
.	NULL

Because	NULL
AP-1	NULL
is	NULL
reported	NULL
to	NULL
be	NULL
downstream	NULL
of	NULL
the	NULL
MAPK	NULL
cas-cade	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
overexpressed	NULL
Bcl-2	NULL
protein	NULL
on	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
.	NULL

When	NULL
U937y	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
for	NULL
6	NULL
h	NULL
,	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
markedly	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
AP-1	NULL
activity	NULL
induced	NULL
by	NULL
bufalin	NULL
was	NULL
slightly	NULL
reduced	NULL
in	NULL
bc/-2-transfected	NULL
U937ai.q	NULL
cells	NULL
and	NULL
significantly	NULL
in	NULL
Bcl-2-transfected	NULL
U937	NULL
,	NULL
.	NULL

,	NULL
;	NULL
,	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
Bcl-2	NULL
protein	NULL
inhibits	NULL
the	NULL
activation	NULL
of	NULL
MAPK	NULL
induced	NULL
by	NULL
bufalin	NULL
,	NULL
and	NULL
this	NULL
leads	NULL
to	NULL
the	NULL
decreased	NULL
transcriptional	NULL
activity	NULL
of	NULL
AP-1	NULL
.	NULL

Discussion	NULL
Here	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
Bcel-2	NULL
overexpression	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
bufalin	NULL
treatment	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

When	NULL
wild-type	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
,	NULL
such	NULL
as	NULL
cell	NULL
viability	NULL
,	NULL
chromosomal	NULL
DNA	NULL
laddering	NULL
,	NULL
and	NULL
morphological	NULL
change	NULL
of	NULL
the	NULL
cells	NULL
and	NULL
nuclei	NULL
,	NULL
indicated	NULL
that	NULL
bufalin	NULL
induced	NULL
typical	NULL
apoptosis	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
apoptosis	NULL
induced	NULL
by	NULL
bufalin	NULL
was	NULL
attenuated	NULL
in	NULL
be/-2-transfected	NULL
U937	NULL
cells	NULL
.	NULL

When	NULL
wild-type	NULL
U937	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
bufalin	NULL
,	NULL
the	NULL
anomalous	NULL
activation	NULL
of	NULL
MAPK	NULL
was	NULL
observed	NULL
(	NULL
10	NULL
)	NULL
.	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
Bcl-2	NULL
and	NULL
the	NULL
signaling	NULL
pathway	NULL
of	NULL
MAPK	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
Bcl-2	NULL
on	NULL
the	NULL
MAPK	NULL
pathway	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
activities	NULL
of	NULL
MAPKK-1	NULL
and	NULL
MAPK	NULL
in	NULL
Bcl-2-overexpressing	NULL
U937	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
with	NULL
bufalin	NULL
.	NULL

There	NULL
was	NULL
a	NULL
marked	NULL
activation	NULL
of	NULL
MAPKK-1	NULL
induced	NULL
by	NULL
bufalin	NULL
in	NULL
as	NULL
well	NULL
as	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
and	NULL
U937	NULL
,	NULL
,	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
Bel-2	NULL
does	NULL
not	NULL
act	NULL
upstream	NULL
of	NULL
MAPKK-1	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
result	NULL
,	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
demonstrated	NULL
that	NULL
Bcl-2	NULL
protein	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
Ras	NULL
or	NULL
Raf-1	NULL
in	NULL
the	NULL
apoptosis	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
deprivation	NULL
of	NULL
a	NULL
diploid	NULL
hematopietic	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
Bel-2	NULL
overexpression	NULL
on	NULL
MAPKK-1	NULL
activity	NULL
,	NULL
a	NULL
significant	NULL
inhibition	NULL
of	NULL
the	NULL
MAPK	NULL
activity	NULL
was	NULL
observed	NULL
.	NULL

Although	NULL
the	NULL
MAPK	NULL
activity	NULL
in	NULL
the	NULL
vector-transfected	NULL
cells	NULL
increased	NULL
approximately	NULL
1.9-fold	NULL
upon	NULL
treatment	NULL
with	NULL
10~®	NULL
m	NULL
bufalin	NULL
,	NULL
the	NULL
activation	NULL
was	NULL
significantly	NULL
inhibited	NULL
in	NULL
Bcl-2-overexpressing	NULL
cells	NULL
,	NULL
especially	NULL
in	NULL
U937	NULL
,	NULL
,	NULL
._	NULL
,	NULL
,	NULL
,	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
indicate	NULL
that	NULL
Bcel-2	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
downstream	NULL
of	NULL
MAPKK-1	NULL
and	NULL
upstream	NULL
of	NULL
MAPK	NULL
in	NULL
the	NULL
MAPK	NULL
signaling	NULL
pathway	NULL
in	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
bufalin	NULL
.	NULL

AP-1	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
located	NULL
downstream	NULL
of	NULL
MAPK	NULL
,	NULL
and	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
AP-1	NULL
is	NULL
affected	NULL
by	NULL
MAPK	NULL
(	NULL
15	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
bufalin	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
AP-1	NULL
in	NULL
both	NULL
wild-type	NULL
and	NULL
vector-transfected	NULL
cells	NULL
,	NULL
but	NULL
approximately	NULL
63	NULL
%	NULL
of	NULL
the	NULL
increased	NULL
activity	NULL
was	NULL
attenuated	NULL
in	NULL
be/-2-overexpressed	NULL
U937n	NULL
.	NULL

;	NULL
.3	NULL
,	NULL
;	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
this	NULL
inhibition	NULL
is	NULL
due	NULL
to	NULL
the	NULL
attenuation	NULL
of	NULL
the	NULL
MAPK	NULL
activity	NULL
caused	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
Bcl-2	NULL
.	NULL

This	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
Bcl-2	NULL
suppresses	NULL
cell	NULL
death	NULL
.	NULL

Further	NULL
work	NULL
is	NULL
needed	NULL
to	NULL
clarify	NULL
the	NULL
physiological	NULL
role	NULL
of	NULL
Bcl-2	NULL
.	NULL

Acknowledgments	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
Dr.	NULL
Tsujimoto	NULL
(	NULL
Osaka	NULL
University	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
be/-2	NULL
cDNA	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
Jaffe	NULL
,	NULL
E.	NULL
,	NULL
Cossman	NULL
,	NULL
J.	NULL
,	NULL
Gotham	NULL
,	NULL
J.	NULL
,	NULL
Nowell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
and	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
Clustering	NULL
of	NULL
breakpoints	NULL
on	NULL
chromosome	NULL
II	NULL
in	NULL
human	NULL
B-cell	NULL
neoplasms	NULL
with	NULL
the	NULL
t	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
chromosome	NULL
translocation	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
375	NULL
:	NULL
340-343	NULL
,	NULL
1985	NULL
.	NULL

2	NULL
.	NULL

Tsujimoto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Croce	NULL
,	NULL
C.	NULL
M.	NULL
Analysis	NULL
of	NULL
the	NULL
structure	NULL
,	NULL
transcripts	NULL
,	NULL
and	NULL
protein	NULL
products	NULL
of	NULL
be/-2	NULL
,	NULL
the	NULL
gene	NULL
involved	NULL
in	NULL
human	NULL
follicular	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

,	NULL
83	NULL
:	NULL
5214-5218	NULL
,	NULL
1986	NULL
.	NULL

3	NULL
.	NULL

Hockenbery	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Oltvai	NULL
,	NULL
Z.	NULL
N.	NULL
,	NULL
Yin	NULL
,	NULL
X-M.	NULL
,	NULL
Milliman	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Korsmeyer	NULL
,	NULL
S.	NULL
J.	NULL
Bcl-2	NULL
functions	NULL
in	NULL
an	NULL
antioxidant	NULL
pathway	NULL
to	NULL
prevent	NULL
apoptosis	NULL
.	NULL

Cell	NULL
,	NULL
75	NULL
:	NULL
241-251	NULL
,	NULL
1993	NULL
.	NULL

4	NULL
.	NULL

Steinman	NULL
,	NULL
H.	NULL
M.	NULL
The	NULL
Bci-2	NULL
oncoprotein	NULL
functions	NULL
as	NULL
a	NULL
pro-oxidant	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
;	NULL
3487-3490	NULL
,	NULL
1995	NULL
.	NULL

5	NULL
.	NULL

Oltvai	NULL
,	NULL
Z.	NULL
N.	NULL
,	NULL
Milliman	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Korsmeyer	NULL
,	NULL
S.	NULL
J.	NULL
Bcl-2	NULL
heterodimerizes	NULL
in	NULL
vivo	NULL
with	NULL
a	NULL
conserved	NULL
homolog	NULL
,	NULL
Bax	NULL
,	NULL
that	NULL
accelerates	NULL
programed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
,	NULL
74	NULL
:	NULL
609-619	NULL
,	NULL
1993	NULL
.	NULL

6	NULL
.	NULL

Wang	NULL
,	NULL
H-G.	NULL
,	NULL
Miyashita	NULL
,	NULL
T.	NULL
,	NULL
Takayama	NULL
,	NULL
S.	NULL
,	NULL
Sato	NULL
,	NULL
T.	NULL
,	NULL
Torigoe	NULL
,	NULL
T.	NULL
,	NULL
Krajewski	NULL
,	NULL
S.	NULL
,	NULL
Tanaka	NULL
,	NULL
S.	NULL
,	NULL
Hovey	NULL
,	NULL
L.	NULL
,	NULL
III	NULL
,	NULL
Troppmair	NULL
,	NULL
J.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Reed	NULL
,	NULL
J.	NULL
C.	NULL
Apoptosis	NULL
regulation	NULL
by	NULL
interaction	NULL
of	NULL
Bcl-2	NULL
protein	NULL
and	NULL
Raf-1	NULL
kinase	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
:	NULL
2751-2756	NULL
,	NULL
1994	NULL
.	NULL

7	NULL
.	NULL

Fernandez-Sarabia	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Bischoff	NULL
,	NULL
J.	NULL
R.	NULL
Bel-2	NULL
associates	NULL
with	NULL
the	NULL
ras-related	NULL
protein	NULL
R-ras	NULL
p23	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
366	NULL
:	NULL
274-275	NULL
,	NULL
1993	NULL
.	NULL

8	NULL
.	NULL

Lowe	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Capon	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Delwart	NULL
,	NULL
E.	NULL
,	NULL
Sakaguchi	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Naylor	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
Structure	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
R-ras	NULL
gene	NULL
,	NULL
novel	NULL
genes	NULL
closely	NULL
related	NULL
to	NULL
ras	NULL
proto-oncogenes	NULL
.	NULL

Cell	NULL
,	NULL
48	NULL
:	NULL
137-146	NULL
,	NULL
1987	NULL
.	NULL

9	NULL
.	NULL

Jing	NULL
,	NULL
Y.	NULL
,	NULL
Ohizumi	NULL
,	NULL
H.	NULL
,	NULL
Kawazoe	NULL
,	NULL
N.	NULL
,	NULL
Hashimoto	NULL
,	NULL
S.	NULL
,	NULL
Masuda	NULL
,	NULL
Y.	NULL
,	NULL
Nakajo	NULL
,	NULL
S.	NULL
,	NULL
Yoshida	NULL
,	NULL
T.	NULL
,	NULL
Kuroiwa	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nakaya	NULL
,	NULL
K.	NULL
Selective	NULL
inhibitory	NULL
effect	NULL
of	NULL
bufalin	NULL
on	NULL
growth	NULL
of	NULL
human	NULL
tumor	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
85	NULL
:	NULL
645-651	NULL
,	NULL
1994	NULL
.	NULL

10	NULL
.	NULL

Watabe	NULL
,	NULL
M.	NULL
,	NULL
Masuda	NULL
,	NULL
Y.	NULL
,	NULL
Nakajo	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Yoshida	NULL
,	NULL
T.	NULL
,	NULL
Kuroiwa	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nakaya	NULL
,	NULL
K.	NULL
The	NULL
cooperative	NULL
interaction	NULL
of	NULL
two	NULL
different	NULL
signaling	NULL
pathways	NULL
in	NULL
response	NULL
to	NULL
bufalin	NULL
induces	NULL
apoptosis	NULL
in	NULL
human	NULL
leukemia	NULL
U937	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
277	NULL
;	NULL
14067-14073	NULL
,	NULL
1996	NULL
.	NULL

11	NULL
.	NULL

Noguchi	NULL
,	NULL
K.	NULL
,	NULL
Nakajima	NULL
,	NULL
M.	NULL
,	NULL
Naito	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Tsuruo	NULL
,	NULL
T.	NULL
Inhibition	NULL
by	NULL
differentiation-inducing	NULL
agents	NULL
of	NULL
wild-type	NULL
p53-dependent	NULL
apoptosis	NULL
in	NULL
HL-60	NULL
cells	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
86	NULL
:	NULL
217-223	NULL
,	NULL
1995	NULL
.	NULL

12	NULL
.	NULL

Chomczynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
162	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

13	NULL
.	NULL

Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
eds	NULL
.	NULL
)	NULL

.	NULL

Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
pp	NULL
.	NULL

188-206	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1982	NULL
.	NULL

14	NULL
.	NULL

Masuda	NULL
,	NULL
Y.	NULL
,	NULL
Kawazoe	NULL
,	NULL
N.	NULL
,	NULL
Shigeo	NULL
,	NULL
N.	NULL
,	NULL
Yoshida	NULL
,	NULL
T.	NULL
,	NULL
Kuroiwa	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nakaya	NULL
,	NULL
K.	NULL
Bufalin	NULL
induces	NULL
apoptosis	NULL
and	NULL
influences	NULL
the	NULL
expression	NULL
of	NULL
apoptosis-related	NULL
genes	NULL
in	NULL
human	NULL
leukemia	NULL
cells	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
79	NULL
:	NULL
549-556	NULL
,	NULL
1995	NULL
.	NULL

15	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
The	NULL
role	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
in	NULL
the	NULL
fos-jun	NULL
interaction	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
336	NULL
:	NULL
646-651	NULL
,	NULL
1988	NULL
.	NULL

3100	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Bcl-2	NULL
Protein	NULL
Inhibits	NULL
Bufalin-induced	NULL
Apoptosis	NULL
through	NULL
Inhibition	NULL
of	NULL
Mitogenactivated	NULL
Protein	NULL
Kinase	NULL
Activation	NULL
in	NULL
Human	NULL
Leukemia	NULL
U937	NULL
Cells	NULL
Masahiko	NULL
Watabe	NULL
,	NULL
Nobuko	NULL
Kawazoe	NULL
,	NULL
Yutaka	NULL
Masuda	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1997	NULL
;	NULL
57:3097-3100	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/57/15/3097	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/57/15/3097	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1997	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

